<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Byrd A</submitter><funding>NIA NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>Michigan Alzheimer's Disease Research Center</funding><funding>National Institutes of Health</funding><funding>University of Arizona</funding><funding>Michigan Alzheimer’s Disease Research Center</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>National Science Foundation</funding><pagination>e202212064</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12777955</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>225(2)</volume><pubmed_abstract>A pathological hallmark in >97% of amyotrophic lateral sclerosis (ALS) cases is the cytoplasmic mislocalization and aggregation of TDP-43, a nuclear RNA-binding protein, in motor neurons. Driving clearance of cytoplasmic TDP-43 reduces toxicity in ALS models, though how TDP-43 clearance is regulated remains controversial. We conducted an unbiased yeast screen using high-throughput dot blotting to identify genes that affect TDP-43 levels. We identified ESCRT complex genes, which induce membrane invagination (particularly at multivesicular bodies; MVBs) and genes linked to K63 ubiquitination (particularly cofactors of the E3 ubiquitin ligase Rsp5; NEDD4 in humans), as drivers of TDP-43 endolysosomal clearance. TDP-43 colocalized and bound Rsp5/NEDD4 and ESCRT proteins, and perturbations to e</pubmed_abstract><journal>The Journal of cell biology</journal><pubmed_title>Rsp5/NEDD4 and ESCRT regulate TDP-43 toxicity and turnover via an endolysosomal clearance mechanism.</pubmed_title><pmcid>PMC12777955</pmcid><funding_grant_id>R01GM114564</funding_grant_id><funding_grant_id>F31NS141379</funding_grant_id><funding_grant_id>F31 NS134123</funding_grant_id><funding_grant_id>P330AG072931</funding_grant_id><funding_grant_id>F31NS134123-01</funding_grant_id><funding_grant_id>R56 NS128110</funding_grant_id><funding_grant_id>R56NS128110</funding_grant_id><funding_grant_id>T32 GM136536</funding_grant_id><funding_grant_id>DGE-1746060</funding_grant_id><funding_grant_id>P30 AG072931</funding_grant_id><funding_grant_id>R01 GM114564</funding_grant_id><funding_grant_id>R01NS113943</funding_grant_id><funding_grant_id>F31 NS141379</funding_grant_id><funding_grant_id>R01 NS113943</funding_grant_id><funding_grant_id>R01NS097542</funding_grant_id><funding_grant_id>R01 NS097542</funding_grant_id><funding_grant_id>T32GM136536</funding_grant_id><pubmed_authors>Dykstra MM</pubmed_authors><pubmed_authors>Byrd A</pubmed_authors><pubmed_authors>Marcinowski S</pubmed_authors><pubmed_authors>Addison V</pubmed_authors><pubmed_authors>Marmorale LJ</pubmed_authors><pubmed_authors>Buchan JR</pubmed_authors><pubmed_authors>Barmada SJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Rsp5/NEDD4 and ESCRT regulate TDP-43 toxicity and turnover via an endolysosomal clearance mechanism.</name><description>A pathological hallmark in >97% of amyotrophic lateral sclerosis (ALS) cases is the cytoplasmic mislocalization and aggregation of TDP-43, a nuclear RNA-binding protein, in motor neurons. Driving clearance of cytoplasmic TDP-43 reduces toxicity in ALS models, though how TDP-43 clearance is regulated remains controversial. We conducted an unbiased yeast screen using high-throughput dot blotting to identify genes that affect TDP-43 levels. We identified ESCRT complex genes, which induce membrane invagination (particularly at multivesicular bodies; MVBs) and genes linked to K63 ubiquitination (particularly cofactors of the E3 ubiquitin ligase Rsp5; NEDD4 in humans), as drivers of TDP-43 endolysosomal clearance. TDP-43 colocalized and bound Rsp5/NEDD4 and ESCRT proteins, and perturbations to e</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-06-06T11:32:55.334Z</modification><creation>2026-05-29T03:13:15.454Z</creation></dates><accession>S-EPMC12777955</accession><cross_references><pubmed>41498748</pubmed><doi>10.1083/jcb.202212064</doi></cross_references></HashMap>